Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Marh�ll, Alissa

Class:Id	Person:9697907
_displayName	Marh�ll, Alissa
_timestamp	2020-08-21 14:01:48
created	[InstanceEdit:9697910] Rothfels, Karen, 2020-08-21
firstname	Alissa
initial	A
surname	Marh�ll
(author)	[LiteratureReference:9697909] Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD [LiteratureReference:9703529] Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation [LiteratureReference:9706052] ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling [LiteratureReference:9706150] The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation
[Change default viewing format]

No pathways have been reviewed or authored by Marh�ll, Alissa (9697907)